August 2026 in “Dermatology and Therapy” This study conducted in the Kingdom of Saudi Arabia reported that severe alopecia areata presents significant treatment challenges due to limited therapies, leading to substantial impacts on patients' quality of life, mental health, and economic burdens.
June 2026 in “International Journal of Innovative Technologies in Social Science” This review highlights the broad range of adverse effects associated with isotretinoin in acne treatment and examines strategies such as dietary supplementation and adjusted dosing protocols to enhance patient tolerability while maintaining efficacy.
June 2026 in “British Journal of Dermatology” This retrospective audit found that patients with alopecia areata often experience significant psychological distress, yet proper mental health assessments and referrals to support services are infrequently conducted, highlighting a gap between current practice and guideline recommendations for comprehensive care.
May 2026 in “Advances in Therapy” This paper emphasizes the importance of holistic and compassionate management of obesity and PCOS in adolescent girls, advocating for improved healthcare prioritization and environmental reform to address complex challenges during adolescence.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that academic stress, family history, and lifestyle factors are significantly associated with hair loss among pharmacy students and faculty in a private college in Telangana, India.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that hair loss among students and faculty at a private pharmacy college in Telangana, India, was significantly associated with academic stress, family history, and lifestyle factors.
This source explores the diverse benefits of basil oil, highlighting its use in aromatherapy for stress relief, as a remedy for skin and respiratory issues, and in traditional medicine for its antiseptic and anti-inflammatory properties.
March 2026 in “International Journal of Innovative Technologies in Social Science” This study reviewed literature to evaluate how regular physical activity affects women with PCOS, finding that both aerobic and resistance exercises can significantly improve insulin resistance, body composition, cardiorespiratory fitness, and mental health while reducing PCOS symptoms.
January 2026 in “IOSR Journal of Dental and Medical Sciences” In this cross-sectional study, researchers observed that acne vulgaris is highly prevalent among adults and found that inadequate sleep is significantly associated with more severe acne, while diet and stress showed no significant link. Additionally, acne negatively impacts psychosocial well-being, affecting individuals' social interactions.
December 2025 in “The Journal of Clinical Psychiatry” Finasteride is not proven to cause depression or suicide, and careful patient monitoring is advised.
November 2025 in “Gynecological Endocrinology” This review discusses coordinated management strategies for polycystic ovary syndrome across various levels of care but reports no new clinical results.
October 2025 in “Dermatology and Therapy” This study found that adults with alopecia areata, particularly women and those affected by the COVID-19 pandemic, have an increased risk of developing new psychiatric disorders.
September 2025 in “Journal of Cosmetic Dermatology” This review found that hair transplantation can positively impact self-esteem and emotional well-being when patients are properly screened for psychological risk factors, but inadequate screening may lead to dissatisfaction or worsened mental health.
September 2025 in “Journal of the American Academy of Dermatology” Alopecia areata is linked to a higher risk of psychiatric disorders.
August 2025 in “Journal of the Korean Society of Cosmetology” This study found that among office workers in Seoul and Gyeonggi Province, hair loss stress significantly correlates with increased interest in appearance and consumption of scalp care products, with variations in impact depending on the type of stress experienced.
July 2025 in “Journal of Education Health and Sport” This review found that androgenetic alopecia may be associated with increased risks of cardiovascular disease, metabolic disorders, and mental health impacts, suggesting its potential as a biomarker for systemic conditions.
April 2025 in “Archives of Dermatological Research” This study found that in patients with androgenetic alopecia, microneedling therapy led to significantly higher treatment adherence compared to medication, with improved adherence linked to factors like age, education, income, reduced side effects, and enhanced treatment efficacy.
February 2025 in “Clinical Cosmetic and Investigational Dermatology” This study suggests that androgenetic alopecia may increase the risk of developing depression, but depression does not significantly contribute to the onset of androgenetic alopecia.
January 2025 in “Journal of Men s Health” This article reports that the rise in erectile dysfunction among young men may be linked to mental health issues and societal pressures, with online communities often encouraging risky substance use like anabolic steroids and finasteride, which can exacerbate psychological and physical health problems.
January 2025 in “Digital Repository (National Repository of Grey Literature)” In this study, analysis of questionnaire data from over 111,000 respondents revealed that red hair is significantly associated with a higher level of mental health problems in both men and women, while red-haired women also exhibited poorer overall physical health.
August 2024 in “International Journal of Health Science” This narrative review found that Telogen Effluvium significantly affects women in Brazil due to its psychological impact and limited access to treatment, exacerbated by economic and healthcare disparities.
June 2024 in “British Journal of Dermatology” This narrative focuses on the experiences of two women with permanent chemotherapy-induced alopecia, highlighting the severe psychological and social impact along with dissatisfaction over pre-treatment information about hair loss, which they initially believed to be temporary.
June 2024 in “Ukrains kyi Visnyk Psykhonevrolohii” This study found that among women with diffuse alopecia, depressive symptoms were common, affecting more than a third of patients, particularly those with mixed alopecia, where the prevalence was three times higher compared to metabolic alopecia.
This review explores the risk factors, associated comorbidities, and psychological impacts of early-onset androgenetic alopecia, highlighting its complexity and potential implications for treatment response and overall health.
March 2024 in “Clinical, cosmetic and investigational dermatology” This study found that severe alopecia areata significantly impacts quality of life, mental health, and daily activities, particularly among women and those with a longer disease duration.
February 2024 in “Recima21” This study explored the connections between Covid-19 and hair loss issues like telogen effluvium and alopecia areata, highlighting the virus's potential trigger effect and underscoring the importance of comprehensive post-Covid-19 treatment strategies that consider immune, psychological, and hair cycle factors.
February 2024 in “World journal of clinical cases” This case study reported a 24-year-old woman with a trichobezoar causing a bowel obstruction, which required surgical removal to prevent serious complications, leading to a full recovery after treatment.
January 2024 in “JEADV clinical practice” This study reported high patient satisfaction with multidisciplinary shared medical appointments for alopecia areata and frontal fibrosing alopecia, with participants appreciating the educational and supportive group environment.
In this study, nearly 38% of Saudi women with PCOS reported extremely severe depression and extreme anxiety, with higher rates linked to young age, divorce, lifestyle advice, and higher BMI.
January 2024 in “Annals of Dermatology” This study highlights the lack of sufficient Korean epidemiological research examining the psychosocial aspects of female pattern hair loss, the leading cause of hair loss among women.